Clinical Trial Update: Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating abacavir when co-administered with boosted darunavir/ritonavir or with raltegravir in HIV-infected subjects. The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Raltegravir (raltegravir)
• abacavir (abacavir)
• darunavir/ritonavir (darunavir/ritonavir)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV | Phase 1 | Status: COMPLETED